Transcutaneous Auricular Vagus Nerve Stimulation for Treating Post-stroke Dysphagia
Recruiting
N/A
Interventional Study
Dysphagia Following Cerebrovascular Accident
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Campus Bio-Medico University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the present project is to use transcutaneous auricular vagus nerve stimulation (t-VNS) for the treatment of dysphagia in acute stroke patients to improve swallowing function and reduce mortality and disability related to this condition.
30 patients will be randomized into one of the two arms of the study:
* REAL: real t-VNS + speech therapy
* SHAM: t-VNS placebo + speech therapy. The …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Acute ischemic or hemorrhagic stroke (within 7 days of onset)
* Dysphagia diagnosed by FEES with a Fiberoptic Endoscopic Dysphagia Severity Scale (FEDSS) score between 3 and 5
Exclusion criteria:
* Pre-existing stroke dysphagia
* Dementia or other medical conditions that may…
Contacts